📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent. (2023)

First Author: Colosimo S

Attributed to: Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.numecd.2022.12.010

PubMed Identifier: 36710114

Publication URI: http://europepmc.org/abstract/MED/36710114

Type: Journal Article/Review

Volume: 33

Parent Publication: Nutrition, metabolism, and cardiovascular diseases : NMCD

Issue: 3

ISSN: 0939-4753